Abstract
Sjögrens syndrome (SS) is an immunologic disorder characterized by progressive destruction of the exocrine glands leading to mucosal and conjunctival dryness.1 Virtually any organ system of the body may be affected in the SS patient, but the disease progress is usually most striking in the salivary and lacrimal glands, where there is a progressive mononuclear cell infiltrate that generally leads to scarring.2 Loss of exocrine function accompanying these tissue changes are responsible for many of the manifestations of SS, including the clinical symptoms of xerostomia and keratoconjunctivitis sicca (KCS).2,3 Patients complain of severe dryness of the mouth and gritty, dry, burning, or itching sensations in the eyes.2 Lack of saliva may cause,oral discomfort, pain, inflammation, mucositis, dysgeusia, candidiasis, increased caries, and periodontal disease. This may lead to poor nutrition and difficulty with social interactions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Moutsopoulos HM. Sjögren’s syndrome. In: Isselbacher J, Braunwald E, Wilson JD, Martin JB, Fauci AS, Petersdorf RG, Root R, eds. Harrison’s Principles of Internal Medicine, 12th ed. New York: McGraw-Hill; 1991: 1449–1450.
Fox RI, Izuno G, Simon RA, Poceta S, Stewart R, Friedlaender MH. Sjögren’s syndrome: A guide for patients. Natl Sjögren’s Syndrome Assoc. 1990; (September 16): 2: 30.
Taylor P. Cholinergie agonists. In: Gilman AG, Goodman LS, Rall TW, Murad F, eds. Goodman and Gil-man’s The Pharmacologic Basis of Therapeutics, 8th ed. New York: Macmillan; 1990: 122–130.
Fox PC, et al. Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia). Arch Intern Med. 1991; 151: 1149–1152.
Greenspan D, Daniels TE. The use of pilocarpine in post-radiation xerostomia. Cancer. 1987; 59: 1123–1125.
Johnson JT, et al. Oral pilocarpine for post-radiation xerostomia in patients with head and neck cancer. N Engl J Med. 1993; 329: 390–395.
LeVeque FG, et al. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J Clin On-col. 1993; 11: 1124–1131.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Papas, A.S., Fernandez, M.M., Castano, R.A., Gallagher, S.C., Trivedi, M., Shrotriya, R.C. (1998). Oral Pilocarpine for Symptomatic Relief of Dry Mouth and Dry Eyes in Patients with Sjögrens Syndrome. In: Sullivan, D.A., Dartt, D.A., Meneray, M.A. (eds) Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2. Advances in Experimental Medicine and Biology, vol 438. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5359-5_139
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5359-5_139
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7445-9
Online ISBN: 978-1-4615-5359-5
eBook Packages: Springer Book Archive